MD Anderson Part of Study Revealing Bevacizumab (Avastin) May Boost

MD Anderson Part of Study Revealing Bevacizumab (Avastin) May Boost

Filed under: Maryland Drug Treatment Centers

bevacizumab – avastin A recent study with the controversial drug bevacizumab (Avastin, Genentech/Roche), provides evidence that this drug therapy increases survival in patients with glioblastoma (brain tumor). … According to Derek Johnson, MD, lead …
Read more on BioNews Texas

 

News Scan for Aug 27, 2013

Filed under: Maryland Drug Treatment Centers

The Centers for Disease Control and Prevention (CDC) has launched a study to identify the long-term health effects of last fall's deadly fungal meningitis outbreak linked to tainted steroids and to determine which antifungal drugs work best, the Boston …
Read more on CIDRAP

 

Where's the Real Danger from Infection This Summer?

Filed under: Maryland Drug Treatment Centers

She survived 25 years in solo practice in rural Cumberland, Maryland, and is now broadening her horizons. She particularly loves …. Originally developed for oncology (cancer treatment), miltefosine is not an entirely new drug; it has been used as …
Read more on Scientific American